Common somatic medications used to combat physical health diseases could bring significant benefits to people with mental illnesses.
Browsing: neuropsychiatric drugs
Two clinical trials of a combined therapy targeting the opioid system have suggested significant symptom reduction in people with major depression.
Dopamine agonists and prodrugs taken to treat Parkinson’s disease may cause impulse control disorders in over half the patients they are prescribed to.
Antidepressants are an effective treatment route for depression, novel study claims.
Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone
In this research article from Journal of Comparative Effectiveness Research, learn how differing drug treatments influence the quality of life of schizophrenia patients.
Novel research clarifies the effects of long-term schizophrenia medication on cognitive function.
In this perspective article, the authors draw attention toward the pharmacoepigenomic influence of antipsychotic drugs, and distinguish its significance from therapeutic response and schizophrenia pathogenesis.
New research describes how eugeroic drug modafinil may improve the memory of individuals recovering from depression.
In this #NCMentalHealthMonth interview, we speak to Miriam Greenberg and Wenxi Yu, who discuss the current hypotheses surrounding the therapeutic mechanisms of anti-bipolar drugs, as well as their hopes for the future of the field of bipolar disorder therapeutics.
Researchers from Vanderbilt University Medical Center (TN, USA) uncover the novel antipsychotic mechanism of muscarinic modulators.